Address & contact
https://www.clinicbarcelona.org/en/service/plastic-surgery/teachingSpecialties
Reports that name this provider
- Cosmetic Surgeon Credentials in Spain
- One plastic surgery resident annually; major teaching programme; accepts international resident fellows for short clinical periods
- Psilocybin Treatment Legality in Spain
- COMPASS Pathways COMP006 Phase 3 trial site
- Specialized Diagnostics in Spain
- First hospital in Spain to remove glomus tumours of middle ear using endoscopic surgery; ranked in top 3 Spanish hospitals globally by Newsweek and Forbes
- Stem Cell Legality in Spain
- Developed ARI-0001 (CART19-BE-01), the first CAR-T cell therapy developed from bench to bedside in the EU through academic channels; authorized by AEMPS in February 2021 for relapsed/refractory acute lymphoblastic leukemia in patients older than 25
- Stem Cell Therapy Availability in Spain
- Barnaclínic+ unit, performed Spain's first allogeneic transplant in 1976, approximately 140 transplants annually, 18 isolation rooms, dedicated apheresis unit, 4–5 weeks average wait time from assessment to procedure, offers remote consultations
- Stem Cell Transplant Quality in Spain
- Also known as barnaclínic+. Performed Spain's first allogeneic transplant in 1976; over 2,100 transplants including over 1,000 allogeneic procedures. 18 equipped isolation rooms with HEPA-filtered air. Reports 70% one-year and 55% five-year overall survival for allogeneic transplants, and 100% one-year and 85% five-year survival for autologous transplants. Manufactures academic ARI-0002h CAR-T for multiple myeloma in-house. Multilingual care (English and French) with dedicated international patient services. Treatment timelines: autologous 4–5 months, related allogeneic 8–9 months, unrelated allogeneic ~12 months. Day hospital open 7 days/week during engraftment. Nurse-to-patient ratio 1:2.